These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 332216)

  • 21. Short term anti-tubercular drug therapy and hepatic microsomal enzyme activity. Antipyrine metabolism as an index.
    Hamide A; Sivagnanam G; Raveendran R; Adithan C; Sivaraman V; Chandrasekar S
    J Assoc Physicians India; 1990 Sep; 38(9):631-2. PubMed ID: 2266077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An attempt at assessment of biotransformation activity in calves' liver on the basis of the rate of antipyrine elimination from saliva].
    Janus K; Baranow-Baranowski S; Jakubowska D
    Pol Arch Weter; 1991; 31(3-4):65-71. PubMed ID: 1842615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Harmatz JS; Shader RI
    J Pharmacol Exp Ther; 1982 Jan; 220(1):120-6. PubMed ID: 7053408
    [No Abstract]   [Full Text] [Related]  

  • 25. Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man.
    Danhof M; de Groot-van der Vis E; Breimer DD
    Pharmacology; 1979; 18(4):210-23. PubMed ID: 461498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination.
    Hepner GW; Vesell ES; Lipton A; Harvey HA; Wilkinson GR; Schenker S
    J Lab Clin Med; 1977 Sep; 90(3):440-56. PubMed ID: 894100
    [No Abstract]   [Full Text] [Related]  

  • 27. Factors affecting antipyrine metabolism in West African villagers.
    Fraser HS; Bulpitt CJ; Kahn C; Mould G; Mucklow JC; Dollery CT
    Clin Pharmacol Ther; 1976 Sep; 20(3):369-76. PubMed ID: 954356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B vaccine and antipyrine clearance.
    Bachmann K; Schwartz J; Jauregui L; Forney R
    J Med; 1985; 16(4):453-9. PubMed ID: 2937866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: Drug metabolism in disease.
    Hepner GW
    Lancet; 1974 May; 1(7865):1048-9. PubMed ID: 4133721
    [No Abstract]   [Full Text] [Related]  

  • 30. Temporal variations of antipyrine half-life in man.
    Vesell ES; Shively CA; Passananti GT
    Clin Pharmacol Ther; 1977 Dec; 22(6):843-52. PubMed ID: 923179
    [No Abstract]   [Full Text] [Related]  

  • 31. Enhanced drug metabolism in cigarette smokers.
    Hart P; Farrell GC; Cooksley WG; Powell LW
    Br Med J; 1976 Jul; 2(6028):147-9. PubMed ID: 1276835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salivary antipyrine half-life during injectable progestagen contraception.
    Joshi JV; Gupta KC; Hazari KT; Gokral J; Pohujani S; Satoskar R
    Clin Pharmacokinet; 1986; 11(2):171-5. PubMed ID: 3956050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical significance of antipyrine metabolism in patients with various liver diseases (author's transl)].
    Takashi M; Musha H; Tsuchiya S; Gotoh N; Takayasu K; Suzuki N; Kotoda K; Okuda K
    Nihon Shokakibyo Gakkai Zasshi; 1981 Feb; 78(2):182-9. PubMed ID: 7241823
    [No Abstract]   [Full Text] [Related]  

  • 34. [2-Acetyl-2-methyl-1-phenyl-hydrazine: a frequently occuring artifact in processing biological material after ingestion of drugs containing antipyrine (author's transl)].
    Zietz E; Spiteller G
    Arzneimittelforschung; 1977 Feb; 27(2):355-6. PubMed ID: 577152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipyrine half-life and drug elimination.
    Breckenridge A
    Clin Pharmacokinet; 1980; 5(3):201-3. PubMed ID: 7389234
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of drug pretreatment on antipyrine elimination in the rabbit.
    Chambers DM; Jefferson GC
    Pharmacology; 1982; 24(2):88-95. PubMed ID: 7079291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of liver volume measurement in the study of antipyrine kinetics in liver disease [proceedings].
    Halliwell M; Homeida M; Roberts CJ
    Br J Clin Pharmacol; 1977 Jun; 4(3):393P-394P. PubMed ID: 901719
    [No Abstract]   [Full Text] [Related]  

  • 38. [Method of evaluating the activity of enzymes metabolizing drugs].
    Semeniuk AV; Kolesnikova LI; Kulikov VIu; Nedle'kina SV; Salganik RI
    Lab Delo; 1982; (10):31-3. PubMed ID: 6183494
    [No Abstract]   [Full Text] [Related]  

  • 39. A sensitive gas-chromatographic assay using a nitrogen-phosphorus detector for determination of antipyrine and aminopyrine in biological fluids.
    Shively CA; Simons RJ; Vesell ES
    Pharmacology; 1979; 19(5):228-36. PubMed ID: 538077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
    Soto Alvarez J; Alsar Ortiz MJ
    Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.